Biotechnology Stocks I Performance Guide: Nuvalent, Inc. (NUVL)
NUVL has no dividends
Table and Chart of NUVL Performance
See what a $1,000 investment in NUVL is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| NUVL Returns | |
|---|---|
| Start Date | Aug-31-2021 |
| Start Price | $36.43 |
| End Date | Dec-01-2023 |
| End Price | $66.20 |
| # Prices | 29 |
| Min Date | May-31-2022 |
| Min Price | $8.86 |
| Max Date | Dec-01-2023 |
| Max Price | $66.20 |
| Total Return | 81.72% |
| Annualized Return | 28.04% |
| Current Value of $1,000 Purchase | $1,817 |
| Number Returns | 406 |
| Average Return | 92.77% |
| Number Profitable Returns | 320 |
| Percent Profitable Returns | 78.82% |
| Number Unprofitable Returns | 86 |
| Percent Unprofitable Returns | 21.18% |
| Profitable to Unprofitable Returns Ratio | 3.72 |
| NUVL Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $4,143,610,000 | Price to Sales |
| Earnings per Share | $-2.0500 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 10.48 |
| PRICE DATA | |
| 52 Week High | $66.44 |
| 52 Week Low | $23.09 |
| Analyst Target Price | $75.43 |
| 50-Day Moving Average | $55.58 |
| 200-Day Moving Average | $42.76 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -0.361% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
NUVL Compare Returns with S&P 500
NUVL Trendline Chart